The scientist’s investigation covers issues in Gerontology, Alzheimer's disease, Disease, Dementia and Internal medicine. His Gerontology research includes elements of Psychological intervention, Physical therapy, Activities of daily living, Geriatrics and Malnutrition. Bruno Vellas combines subjects such as Central nervous system disease, Weight loss, Psychiatry, Cognitive disorder and Cohort with his study of Alzheimer's disease.
His studies in Disease integrate themes in fields like Biomarker, Clinical trial and Alternative medicine. His Dementia study combines topics in areas such as Cognition, MEDLINE and Quality of life. His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo, Surgery and Endocrinology.
His primary areas of study are Gerontology, Disease, Dementia, Internal medicine and Alzheimer's disease. The various areas that he examines in his Gerontology study include Psychological intervention, Sarcopenia, Intervention, Activities of daily living and Geriatrics. He interconnects Observational study, Clinical trial, Intensive care medicine, Physical therapy and Pediatrics in the investigation of issues within Disease.
Bruno Vellas has included themes like Psychiatry, Cognition and MEDLINE in his Dementia study. His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo, Endocrinology and Oncology. His research in Alzheimer's disease intersects with topics in Prospective cohort study, Central nervous system disease, Degenerative disease and Cognitive disorder.
Internal medicine, Disease, Dementia, Gerontology and Cognition are his primary areas of study. The study incorporates disciplines such as Placebo and Oncology in addition to Internal medicine. His Disease study combines topics from a wide range of disciplines, such as Geriatrics gerontology, Neurology, Intensive care medicine and Clinical trial.
His Dementia study integrates concerns from other disciplines, such as Randomized controlled trial, Physical therapy, Activities of daily living, Neuroscience and Pediatrics. His Physical therapy research is multidisciplinary, incorporating elements of Medical prescription and Quality of life. In his research, Integrated care is intimately related to Geroscience, which falls under the overarching field of Gerontology.
Bruno Vellas mostly deals with Internal medicine, Disease, Dementia, Clinical trial and Gerontology. His studies deal with areas such as Placebo and Activities of daily living as well as Internal medicine. The Disease study combines topics in areas such as Biomarker, Neurology, Neuroscience and Intensive care medicine.
Bruno Vellas studies Cognitive decline which is a part of Dementia. His biological study spans a wide range of topics, including Intervention, Geriatrics gerontology and Drug development. His Gerontology research is multidisciplinary, relying on both Sarcopenia, Cohort study, Public health and Polypharmacy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ESPEN Guidelines for Nutrition Screening 2002
J Kondrup;S.P Allison;M Elia;B Vellas.
Clinical Nutrition (2003)
Frailty Consensus: A Call to Action
John E. Morley;Bruno Vellas;G. Abellan van Kan;Stefan D. Anker.
Journal of the American Medical Directors Association (2013)
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.
Roger A. Fielding;Bruno Vellas;William J. Evans;Shalender Bhasin.
Journal of the American Medical Directors Association (2011)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)
Assessing the Nutritional Status of the Elderly: the Mini Nutritional Assessment as Part of the Geriatric Evaluation
Yves Guigoz;Bruno Vellas;Philip J. Garry.
Nutrition Reviews (2009)
The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients
Bruno Vellas;Yves Guigoz;Yves Guigoz;Philip J Garry;Fati Nourhashemi.
Screening for Undernutrition in Geriatric Practice Developing the Short-Form Mini-Nutritional Assessment (MNA-SF)
Laurence Z. Rubenstein;Judith O. Harker;Antoni Salvà;Yves Guigoz.
Journals of Gerontology Series A-biological Sciences and Medical Sciences (2001)
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force
Gabor Abellan Van Kan;Y. Rolland;S. Andrieu;J. Bauer.
Journal of Nutrition Health & Aging (2009)
Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)
Alfonso J. Cruz-Jentoft;Francesco Landi;Stéphane M. Schneider;Clemente Zúñiga.
Age and Ageing (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
RS Rachelle S. Doody;RG Ronald G. Rg Thomas;Martin Farlow;Takeshi Iwatsubo.
The New England Journal of Medicine (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: